Analytical Data
-
基因名
IMPDH1
- Application
-
别名
IMPDH1;IMPD1;Inosine-5'-monophosphate dehydrogenase 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P20839
-
表达区间
1-514aa
-
氨基酸序列
MGSSHHHHHH SSGLVPRGSH MADYLISGGT GYVPEDGLTA QQLFASADGL TYNDFLILPG FIDFIADEVD LTSALTRKIT LKTPLISSPM DTVTEADMAI AMALMGGIGF IHHNCTPEFQ ANEVRKVKKF EQGFITDPVV LSPSHTVGDV LEAKMRHGFS GIPITETGTM GSKLVGIVTS RDIDFLAEKD HTTLLSEVMT PRIELVVAPA GVTLKEANEI LQRSKKGKLP IVNDCDELVA IIARTDLKKN RDYPLASKDS QKQLLCGAAV GTREDDKYRL DLLTQAGVDV IVLDSSQGNS VYQIAMVHYI KQKYPHLQVI GGNVVTAAQA KNLIDAGVDG LRVGMGCGSI CITQEVMACG RPQGTAVYKV AEYARRFGVP IIADGGIQTV GHVVKALALG ASTVMMGSLL AATTEAPGEY FFSDGVRLKK YRGMGSLDAM EKSSSSQKRY FSEGDKVKIA QGVSGSIQDK GSIQKFVPYL IAGIQHGCQD IGARSLSVLR SMMYSGELKF EKRTMSAQIE GGVHGLHSYE KRLY
-
分子量
58 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IMPDH1, or Inosine Monophosphate Dehydrogenase 1, is a key enzyme involved in the de novo synthesis of purine nucleotides, playing a crucial role in cellular proliferation and metabolism. Its primary function is to catalyze the conversion of inosine monophosphate (IMP) to xanthosine monophosphate (XMP), thereby influencing pathways critical for DNA and RNA synthesis. Dysregulation of IMPDH1 has been implicated in various pathological conditions, including cancer and autoimmune diseases, prompting researchers to explore this enzyme as a potential therapeutic target. In addition, IMPDH1 is a known target for certain antiviral and immunosuppressive drugs, thus making it an important focus of pharmacological studies. The recombinant production of IMPDH1 protein has allowed scientists to investigate its biochemical properties, substrate specificity, and interaction with inhibitors, providing insights into its mechanism of action and potential applications in drug development. Overall, this research is vital not only for understanding the fundamental biology of nucleotide metabolism but also for developing innovative therapeutic strategies against diseases associated with IMPDH1 dysfunction.
